PTLAEUR
Portola Pharmaceuticals Inc
Biopharmaceutical company developing therapies for thrombosis and hematologic disorders
CUSIP: 737010108HealthcareUS1 holder
Total Value
$1.25M
Total Shares
52.4K
Net Share Change
+52.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$1.25M52.4K sharesNEW